Niagen Bioscience
NAGE
86 hedge funds and large institutions have $129M invested in Niagen Bioscience in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 20 closing their positions.
67% more call options, than puts
Call options by funds: $2.83M | Put options by funds: $1.69M
28% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 25
0.07% more ownership
Funds ownership: 30.02% → 30.08% (+0.07%)
15% less funds holding
Funds holding: 101 → 86 (-15)
36% less capital invested
Capital invested by funds: $201M → $129M (-$71.7M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
70% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$3.45M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$1.94M |
| 3 |
Barclays
London,
United Kingdom
|
+$1.21M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$460K |
| 5 |
Millennium Management
New York
|
+$419K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$1.42M |
| 2 |
NTIMCH
New Thinking Investment Management Company (HK)
Hong Kong
|
-$1.36M |
| 3 |
JAMONY
Jacob Asset Management of New York
Hermosa Beach,
California
|
-$828K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$557K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$548K |
NAGE Hedge Fund Activity: Q3 2021 in Review
86 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q3 2021, worth a combined $129M — down 36% from $201M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of NAGE and 6 opened new positions — a net loss of 14 holders — while 25 trimmed existing stakes and 32 added.
The largest buyer was Nuveen, adding an estimated $3.45M. The largest seller was Group One Trading, cutting an estimated $1.42M.
- 86 institutional investors held Niagen Bioscience (NAGE) as of Q3 2021, down from 101 in Q2 2021.
- Funds reported $129M of Niagen Bioscience stock for Q3 2021, down 36% quarter-over-quarter.
- 6 funds opened new Niagen Bioscience positions in Q3 2021 and 20 closed out, a net change of -14 holders.
- The largest Niagen Bioscience buyer in Q3 2021 was Nuveen, an estimated $3.45M added.
- The largest Niagen Bioscience seller in Q3 2021 was Group One Trading, an estimated $1.42M sold.
Based on aggregated 13F filings for Q3 2021.